Cytek Biosciences, Inc.
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytomete…
Medical - Devices
US, Fremont [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Cytek Biosciences, Inc.'s gradings, price targets and earnings estimates. None
FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
E | E | E | E | E | E | |||||||
2021 | - | 0.108 | - | 125 | - | 14 | - | 5 | - | 3 | - | 45 |
2022 | 0.0330 | 0.090 | 127 | 166 | 4 | 12 | 10 | 0.20 | 9 | -3 | 45 | 59 |
2023 | 0.0192 | -0.033 | 164 | 190 | 2 | -4 | 9 | 0.23 | -1 | -3 | 67 | 68 |
2024 | -0.0898 | 0.158 | 193 | 204 | -12 | 23 | -4 | 0.24 | -27 | -4 | 91 | 73 |
2025 | - | 0.210 | - | 227 | - | 33 | - | 0.27 | - | -4 | - | 81 |
2026 | - | 2.F5X/td> | - | 2.F5X/td> | - | 2.F5X/td> | - | 2.F51/td> | - | 2.F51 | - | 2.F51 |
2027 | - | 1.F6X/td> | - | 1.F6X/td> | - | 1.F6X/td> | - | 1.F61/td> | - | 1.F61 | - | 1.F61 |
2028 | - | 0.F7X/td> | - | 0.F7X/td> | - | 0.F7X/td> | - | 0.F71/td> | - | 0.F71 | - | 0.F71 |